The FDA has cleared its first automated insulin pump for adults with Type 2 diabetes, with Insulet’s Omnipod 5 delivery system opening the door to a population of more than 6 million people.

An insulin pump delivers insulin in two ways: via a basal rate and bolus doses. A basal rate is a steady flow throughout the day and night, programmed based on units per hour and customizable for ...

Full cartridges — Medtronic: 3 mL, t:slim: 3 mL, and Omnipod: 2 mL — all over-delivered 0.60 units of insulin over a 20-minute ascent compared with delivery at ground level.

It expects Omnipod revenue growth in the range of 17% to 21% for 2025. On an adjusted basis, the company earned $1.15 per share, above analysts' average estimate of $1.02.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its groundbreaking Omnipod ...

Acton company earns approval for first-ever insulin pump for type 2 diabetes. expand. The Omnipod 5 Automated Insulin Delivery System has been approved for people with type 2 diabetes. Insulet Corp.